Vísindastarf

Krabbameinsfélagið gegnir miklu hlutverki í að afla nýrrar þekkingar í heilbrigðisvísindum. 

Vísindaefni

Útgefið vísindaefni 2018


  • Katuwal S, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Weiderpass E, Pukkala E. Occupational variation in the risk of female breast cancer in the Nordic countries. Cancer Causes Control. 2018 Aug 27.
  • Talibov M, Sormunen J, Hansen J, Kjaerheim K, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Benzene exposure at workplace and risk of colorectal cancer in four Nordic countries. Cancer Epidemiol. 2018:55:156-161.
  • Norsker FN, Rechnitzer C, Cederkvist L, Tryggvadottir L, Madanat-Harjuoja LM, Øra I, Thorarinsdottir HK, Vettenranta K, Bautz A, Schrøder H, Hasle H, Winther JF. Somatic late effects in 5-year survivors of neuroblastoma: A population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Int J Cancer. 2018 Jun 21.
  • Jonsdottir T, Valdimarsdottir H, Tryggvadottir L, Lund SH, Thordardottir M, Magnusson MK, Valdimarsdottir U. Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations. Laeknabladid. 2018 Juni;104(6):289-296.
  • Kenborg L, Winther JF, Linnet KM, Krøyer A, Albieri V, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Stovall M, Hasle H, Olsen JH; ALiCCS study group. Neurologic Disorders in 4,858 Survivors of Central Nervous System Tumors in Childhood - an Adult Life after Cancer in Scandinavia (ALiCCS) study. Neuro Oncol. 2018 May 30.
  • Haraldsdottir A, Torfadottir JE, Valdimarsdottir UA, Adami HO, Aspelund T, Tryggvadottir L, Thordardottir M, Birgisdottir BE, Harris TB, Launer LJ, Gudnason V, Steingrimsdottir L. Dietary habits in adolescence and midlife and risk of breast cancer in older women. PLoS One. 2018 May 30;13(5)
  • Rafnar T, Sigurjonsdottir GR, Stacey SN, Halldorsson G, Sulem P, Pardo LM, Helgason H, Sigurdsson ST, Gudjonsson T, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Alexiusdottir K, Sigurdsson A, Gudmundsson J, Saemundsdottir J, Sigurdsson JK, Johannsdottir H, Uitterlinden A, Vermeulen SH, Galesloot TE, Allain DC, Lacko M, Sigurgeirsson B, Thorisdottir K, Johannsson OT, Sigurdsson F, Ragnarsson GB, Isaksson H, Hardardottir H, Gudbjartsson T, Gudbjartsson DF, Masson G, Kiemeney LAML, Ewart Toland A, Nijsten T, Peters WHM, Olafsson JH, Jonsson S, Thorsteinsdottir U, Thorleifsson G, Stefansson K. Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin. J Natl Cancer Inst. 2018 May 14.
  • Andersson TM, Engholm G, Pukkala E, Stenbeck M, Tryggvadottir L, Storm H, Weiderpass E. Avoidable cancers in the Nordic countries-The impact of alcohol consumption. Eur J Cancer. 2018 May 5. pii: S0959-8049(18)30776-7.
  • Andersson TM, Engholm G, Brink AL, Pukkala E, Stenbeck M, Tryggvadottir L, Weiderpass E, Storm H. Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period-The effect of envisaged scenarios changing smoking prevalence. Eur J Cancer. 2018 Mar 29. pii: S0959-8049(18)30239-9.]
  • Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. 2018 Mar;92:108-118.
  • Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar 17;391(10125):1023-1075.
  • Talibov M, Pukkala E, Martinsen JI, Tryggvadottir L, Weiderpass E, Hansen J. Night-shift work and hematological cancers: a population based case-control study in three Nordic countries. Scand J Work Environ Health. 2018 May 1;44(3):258-264.
  • Pukkala, E., Engholm, G., Højsgaard Schmidt, L.K., Storm, H., Khan, S., Lambe, M., Pettersson, D., Ólafsdóttir, E., Tryggvadóttir, L., Hakanen, T., Malila, N., Virtanen, A., Johannesen, T.B., Larønningen, S., Ursin, G.: Nordic Cancer Registries – an overview of their procedures and data comparability. Acta Oncol. 2018; 57:  440-455.


Útgefið vísindaefni 2017


  • Farioli A, Straif K, Brandi G, Curti S, Kjaerheim K, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Biasco G, Violante FS, Mattioli S, Pukkala E. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries. Occup Environ Med. 2017 Nov 13.
  • Barry KH, Martinsen JI, Alavanja MCR, Andreotti G, Blair A, Hansen J, Kjærheim K, Koutros S, Lynge E, Sparèn P, Tryggvadottir L, Weiderpass E, Berndt SI, Pukkala E. Risk of early-onset prostate cancer associated with occupation in the Nordic countries. Eur J Cancer. 2017 Nov 10;87:92-100.
  • Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Wilson KM, Steingrimsdottir L, Aspelund T, Batista JL, Fall K, Giovannucci E, Sigurdardottir LG, Tryggvadottir L, Gudnason V, Markt SC, Mucci LA. Midlife metabolic factors and prostate cancer risk in later life. Int J Cancer. 2017 Nov 7.
  • Tao W, Artama M, von Euler-Chelpin M, Konings P, Ljung R, Lynge E, Ólafsdóttir GH, Pukkala E, Romundstad P, Tryggvadottir L, Wahlin K, Lagergren J. Data Resource Profile: The Nordic Obesity Surgery Cohort (NordOSCo). Int J Epidemiol. 2017 Oct 1;46(5):1367-1367g.
  • Kjaer SK, Nygård M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, Tryggvadottir L, Joshi A, Das R, Saah AJ. A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clin Infect Dis 2017 Oct 1.
  • Bonnesen TG, Winther JF, Andersen KK, Asdahl PH, de Fine Licht S, Gudmundsdottir T, Sällfors Holmqvist A, Madanat-Harjuoja LM, Tryggvadottir L, Wesenberg F, Heilmann C, Olsen JH, Hasle H; ALiCCS study group. Liver diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): A population-based cohort study of 32,839 one-year survivors. Int J Cancer. 2017 Oct 11.
  • Siew SS, Martinsen JI, Kjaerheim K, Sparén P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma. Int J Cancer 2017;141(12):2430-2436.
  • Hadkhale K, MacLeod J, Demers PA, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Anne Harris M, Tjepkema M, Peters PA, Pukkala E. Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada. BMJ Open. 2017;7(8):e016538.
  • Stefansson OA, Hermanowicz S, van der Horst J, Hilmarsdottir H, Staszczak Z, Jonasson JG, Tryggvadottir L, Gudjonsson T, Sigurdsson S.  CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer. BMC Cancer. 2017;17(1):469.
  • Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, Euler-Chelpin MV, Lagergren J.  Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo).  BMJ Open. 2017;7(6):e016505.
  • Talibov M, Auvinen A, Weiderpass E, Hansen J, Martinsen JI, Kjaerheim K, Tryggvadottir L, Pukkala E. Occupational solvent exposure and adult chronic lymphocytic leukemia: No risk in a population-based case-control study in four Nordic countries.  Int J Cancer. 2017;141(6):1140-1147.
  • Tarvainen L, Suojanen J, Kyyronen P, Lindqvist C, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E.  Occupational Risk for Oral Cancer in Nordic Countries. Anticancer Res. 2017 Jun;37(6):3221-3228.
  • de Fine Licht S, Rugbjerg K, Gudmundsdottir T, Bonnesen TG, Asdahl PH, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Hasle H, Winther JF, Olsen JH; ALiCCS study group.. Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors. PLoS Med. 2017;14(5):e1002296.
  • Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, Gudjonsson SA, Gudmundsson J, Jonasson JG, Tryggvadottir L, Jonsson T, Helgason A, Gylfason A, Sulem P, Rafnar T, Thorsteinsdottir U, Gudbjartsson DF, Masson G, Kong A, Stefansson K. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 2017 May 8. pii: blood-2017-02-769869. doi: 10.1182/blood-2017-02-769869. [Epub ahead of print]
  • Crujeiras AB, Díaz-Lagares A, Stefansson OA, Macias M, Sandoval J, Cueva J, López-López R, Moran S, Jonasson JG, Tryggvadottir L, Olafsdottir E, Tinahones FJ, Carreira MC, Casanueva FF, Esteller M. Obesity and menopause modify the epigenomic profile of breast cancer. Endocr Relat Cancer 2017 Apr 25. pii: ERC-16-0565. doi: 10.1530/ERC-16-0565. [Epub ahead of print]
  • Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group.. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202-e217.
  • Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group..  Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 2017;77:140-152.
  • Kjartansdottir OJ, Sigurdardottir LG, Olafsdottir EJ, Jonasson JG, Ursin G, Tryggvadottir L. Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women. Breast Cancer Res Treat. 2017;163(2):363-373.
  • Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Pukkala E. Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries. Int J Cancer. 2017;140(8):1736-1746.



Útgefið vísindaefni 2016

HeimildKrabbameinsskrá

Útgefið vísindaefni 2015

HeimildKrabbameinsskrá

Útgefið vísindaefni 2014

Heimild: Krabbameinsskrá

Útgefið vísindaefni 2013

  • Alexiusdottir KK, Möller PH, Snaebjornsson P, Jonasson L, Olafsdottir EJ, Bjornsson ES, Tryggvadottir L, Jonasson JG.  Colon Cancer: Association of Histopathological Parameters and Patients' Survival with Clinical Presentation.  APMIS 2013: 121(10); 901-907 (DOI 10.1111/apm.12109).
  • Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, Holleczek B, Tryggvadóttir L, Comber H, Bento MJ, Diba CS, Micallef R, Primic-Žakelj M, Izarzugaza MI, Perucha J, Marcos-Gragera R, Galceran J, Ardanaz E, Schaffar R, Pring A, de Vr  Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol. 2013 Aug 21. 
  • Bjornsson ES, Jonasson JG.  Drug-induced cholestasis. Clin Liver Dis 2013: May;17(2):191-209. Doi: 10.1016/j.cld.2012.11.002. Epub 2012 Dec 20. 
  • Brasso K, Ingimarsdóttir IJ, Rusch E, Engholm G, Adolfsson J, Tryggvadóttir L, Jónsson E, Bill-Axelson A, Holmberg E, Storm HH.  Differences in survival from prostate cancer in Denmark, Iceland and Sweden. Eur J Cancer. 2013 May;49(8):1984-92. 
  • De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R, The Eurocare-5 Working Group (... Jonasson JG....).  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol. Birt online 5. Desember 2013: dx.doi.org/10.1016/S1470-2045(13)70546-1; bls 1-12 + suppl. online. 
  • Fallah M, Pukkala E, Tryggvadottir L, Olsen JH, Tretli S, Sundquist K, Hemminki K.  Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet. 2013 Jun;50(6):373-82. 
  • Gatta G, Botta L, Rossi S, Aereleid T, Bielska-Lasota M,Clavel J, Dimitrova N, Jakob Z, Kaatsch P, Lacour B, Mallone S, Marcos_Gragera R, Minicozzi P, Sánchez-Pérez M-J, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R, ant t  Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 – a population-based study. Lancet Oncol. Birt online 5. Desember 2013: dx.doi.org/10.1016/S1470-2045(13)70548-5; bls 1-13 + suppl. online 
  • Gunnarsdottir HK, Vidarsdottir H, Rafnsdottir GL, Tryggvadottir L, Olafsdottir EJ, Lindbohm ML.  Employment participation and work experience of male cancer survivors: A NOCWO studyWork. 2013 Sep 4. 
  • Styrkarsdottir U, Thorleifsson G, Gudbjartsson D, Sulem P, Sigurdsson A, Jonasdottir A, Jonasdottir A, Oddsson A, Helgason A, Magnusson OT, Walters GB, Frigge ML, Helgadottir HT, Johannsdottir H, Bergsteinsdottir K, Ogmundsdottir MH, Center JR, Nguyen T  VNonsense mutation in the LGR4 gene associates with several human diseases and other traits. Nature 2013; 597, May: 517-520. 
  • Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L.  Consumption of Fish Products across the Lifespan and Prostate Cancer Risk. PLoS One. 2013 Apr 17;8(4):e59799. 
  • Tryggvadottir L, Olafsdottir EJ, Olafsdottir GH, Sigurdsson H, Johannsson OT, Stefansson OA, Agnarsson BA, Eyfjord J, Jonasson JG.  Tumour Diploidy and Survival in Breast Cancer Patients with BRCA2 mutationBreast Cancer Research and Treatment 2013: 140(2); 375-384 (DOI 10.1007/s10549-013-2637-4). 
  • Vlaanderen J, Straif K, Martinsen JI, Kauppinen T, Pukkala E, Sparén P, Tryggvadottir L, Weiderpass E, Kjaerheim K.   Cholangiocarcinoma among workers in the printing industry: using the NOCCA database to elucidate the generalisability of a cluster report from Japan. Occup Environ Med. 2013 Dec;70(12):828-30. 
  • Vlaanderen J, Straif K, Pukkala E, Kauppinen T, Kyyrönen P, Martinsen JI, Kjaerheim K, Tryggvadottir L, Hansen J, Sparén P, Weiderpass E.  Occupational exposure to trichloroethylene and perchloroethylene and the risk of lymphoma, liver, and kidney cancer in four Nordic countries. Occup Environ Med. 2013 Jun;70(6):393-401. 

HeimildKrabbameinsskrá

Útgefið vísindaefni 2012

  • Alexiusdottir KK, Möller PH, Snaebjornsson P, Jonasson L, Olafsdottir EJ, Björnsson ES, Tryggvadottir L, Jonasson JG.  Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scand J Gastroenterol. 2012 Apr 17.
  • Allemani C, Sant M, Weir HK, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP.  Breast cancer survival in the US and Europe: A CONCORD high-resolution study. Int J Cancer 2012 Jul 20. doi: 10.1002/ijc.27725.
  • Baldursdottir TR, Bergmann OM, Jonasson JG, Ludviksson BR, Axelsson TA, Bjornsson ES.  The incidence, prevalence and the natural history of primary biliary cirrhosis: a nationwide population based study from Iceland. Eur J Gastroenterology and Hepatology 2012: 24 (7): 824-830.
  • Bergmann OB, Kristjansson G, Jonasson JG, Bjornsson ES.  Jaundice due to suspected statin hepatotoxicity: a case series. Digestive Diseases and Sciences 2012; 57 (7): 1959-1964.
  • Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Helgadottir HT, Li W, Nagy R, Ringel MD, Kloos RT, de Visser MC, Plantinga TS, den Heijer M, Aguillo E, Panadero A, Prats E, Gar  Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012 Jan 22. doi: 10.1038/ng.1046.
  • Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Agnarsson BA, Benediktsdottir KR, Sigurdsson A, Magnusson OT, Gudjonsson SA, Magnusdottir DN, Johannsdottir H, Helgadottir HT, Stacey SN, Jonasdottir A, Olafsdottir SB, Thorleifsson G, Jonasson JG, Tryggv  A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Nat Genet. 2012 Oct 28. doi: 10.1038/ng.2437.
  • Joensuu H, Vehtari A, Riihimäki J, Nishida T, Eriksson SS, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson M, Linke Z, Suffliarsky J, Massimo F, Jonasson JG, Dei Tos AP, Rutkowski P.  Risk of gastrointestinal stromal tumour recurrence after surgery: an analysis based on pooled population-based cohorts. Lancet Oncology 2012; 13 (3): 265-274. 
  • Jonsdottir AB, Stefansson OA, Bjornsson J, Jonasson JG, Ogmundsdottir HM, Eyfjord JE.  Tetraploidy in BRCA2 breast tumours. Eur J Cancer 2012; 48 (3): 305-310
  • Koivisto-Korander R, Scélo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E.  Second primary malignancies among women with uterine sarcoma. Gynaecologic Oncology 2012; 126 (1): 30-35. 
  • Rubio CA, Kristjansdottir, Thodleifsson B, Olafsdottir E, Jonasson JG.  The frequency of advanced adenoma in consulting patients. A nationwide survey in Iceland (2003-2006). Colorectal Disease 2012; 14 (9): e595-e602. 
  • Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, Tryggvadottir L.  Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completeness. Acta Oncol. 2012 Sep;51(7):880-9. 
  • Stefansdottir V, Johannsson OT, Skirton H, Tryggvadottir L, Tulinius H, Jonsson JJ.  The use of genealogy databases for risk assessment in genetic health service: asystematic review. J Community Genet. 2012 Jul 18. 
  • Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, Barbalic M, Broer L, Byrne EM, Ernst F, Esko T, Franceschini N, Gudbjartsson DF, Hottenga JJ, Kraft P, McArdle PF, Porcu E, Shin SY, Smith AV, van Wingerden S, Zhai G, Zhuang WV, Albrecht E,  AlizadeMeta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet. 2012 Jan 22. doi: 10.1038/ng.1051. [Epub ahead of print]
  • Talibov M, Kautiainen S, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E.  Occupation and Leukemia in Nordic Countries. J Occup Environ Med. 2012 Oct 30. 
  • Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA.  Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol. 2012 Jan 15;175(2):144-53. 
  • Torfadottir JE, Valdimarsdottir UA, Mucci L, Stampfer M, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Adami HO, Gudnason V, Steingrimsdottir L.  Rye bread consumption in early life and reduced risk of advanced prostate cancer. Cancer Causes Control;23(6):941-50.2012. 
  • Tukenova M, Diallo I, Anderson H, Hawkins M, Garwicz S, Sankila R, El Fayech C, Winter D, Rubino C, Adjadj E, Haddy N, Oberlin O, Moller T, Langmark F, Tryggvadottir L, Pacquement H, Svahn-Tapper G, de Vathaire F.  Second malignant neoplasms in digestive organs after childhood cancer: a cohort-nested case-control study. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e383-90.
  • Vidarsdottir H, Möller PH, Jonasson JG, Pfannschmidt J, Gudbjartsson T.  Indications and Surgical Outcome Following Pulmonary Metastasectomy – A Nation-wide Study. Thoracic and Cardiovascular Surgeon 2012; 60 (6): 383-389.

HeimildKrabbameinsskrá

Útgefið vísindaefni 2011

  • Arnadottir M, Jonasson JG, Indridason OS.  Encapsulating peritoneal sclerosis with a foreign body reaction. NDT Plus Nephrology Dialysis Transplantation) 2011; 10.1093/ntplus/sfq202.
  • Arnadottir M, Jonasson JG, Indridason OS.  Encapsulating peritoneal sclerosis with a foreign body reaction. NDT Plus (Nephrology Dialysis Transplantation) 2011; 4(2):107-109.
  • Bergmann OB, Kristjansson G, Jonasson JG, Bjornsson ES.  Jaundice due to suspected statin hepatotoxicity: a case series. Digestive Diseases and Sciences 2011; DOI10.1007/s10620-011-1950-1. bls 1-6.
  • Bosetti C, Scélo G, Chuang SC, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Olsen JH, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Brennan P, Hashibe M, Levi F, Vecchia CL, Boffetta P.  High constant incidence of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer 2011; 129(1): 173-179.
  • Jensen KE, Munk C, Sparen P, Tryggvadóttir L, Liaw KL, Dasbach E, Nygård M, Kjaer SK.  Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand. 2011 Jan 4. doi: 10.1111/j.1600-0412.2010.01066.x.
  • Joensuu H, Vehtari A, Riihimäki J, Nishida T, Eriksson SS, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson M, Linke Z, Suffliarsky J, Massimo F, Jonasson JG, Dei Tos AP, Rutkowski P.  Risk of gastrointestinal stromal tumour recurrence after surgery: an analysis based on pooled population-based cohorts. Lancet Oncology 2011; DOI:10.1016/s1470-2045(11)70299-6.
  • Jónasson JG, Hrafnkelsson J, Ólafsdóttir E.Skjaldkirtilskrabbamein á Íslandi tímabilið 1955-2004.  Klínísk og meinafræðileg faraldsfræðirannsókn. Læknablaðið 2011; 97: 83-89.
  • Jónasson JG, Hrafnkelsson J, Ólafsdóttir E.  Skjaldkirtilskrabbamein á Íslandi tímabilið 1955-2004. Klínísk og meinafræðileg faraldsfræðirannsókn. Læknablaðið 2011; 97: 83-89.
  • Jonasson JG.  Áður dauðadómur – nú sjúkdómur. Ritstjórnargrein (editorial) Læknablaðið 2011; 97: 141.
  • Jonsdottir AB, Stefansson OA, Bjornsson J, Jonasson JG, Ogmundsdottir HM, Eyfjord JE.  Tetraploidy in BRCA2 breast tumours. Eur J Cancer 2011; DOI:10.1016/j.ejca.2011.11.008
  • Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Olsen JH, Tracey E, Pukkala E, Weiderpass Vainio E, Brewster DH, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P.  Second malignancies after childhood noncentral nervous system solid cancers: results from 13 cancer registries. Int J Cancer 2011; 129: 1940-1952.
  • Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, Jonasdottir A, Besenbacher S, Lundin P, Stacey SN, Gudmundsson J, Magnusson O, le Roux L, Orlygsdottir G, Helgadottir H, Johannesdottir H, Gylfason A, Tryggvadotir L, Jonasson JG, De Juan A,  Mutation in BRIP1 confer high risk of ovarian cancer. Nature Genetics 2011: 43(11): 1104-1107. Advance online publication
  • Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsberger-van de Kaa C, Besenbacher S, Gudbjartsson D, Stacey S, Gudmundsson J, Johannesdottir H, Bjarnason H, Zanon C, Helgadottir H, Jonasson JG, Tryggvado  European Genome-Wide Association Study Identifies SLC14A1 as a NewUrinary Bladder Cancer Susceptability Gene. Hum Mol Genet 2011; 20 (21): 4268-4281.
  • Stacey S, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson D, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexö BA, Tjönneland A, Overvad K, Rudnai P, Gurzau E, Koppova K, Hemminki K, Correde  A Germline Variant in the 3' UTR of TP53 Confers Susceptibility to Common Tumours. Nature Genetics 2011: 43(11): 1098-1103. Advance online publication.
  • Stefansson OA, Jonasson JG, Bjarnason H, Johannsson OT, Olafsdottir K, Bodvarsdottir SK, Valgeirsdottir S, Eyfjord JE.  Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression. Breast Cancer Research 2011; 13:R95
  • Stefansson OA, Jonasson JG, Olafsdottir K, Hilmarsdottir H, Olafsdottir G,Esteller M, Johannsson OT, Eyfjord JE.  Epigenetics 2011:6(5);638-649
  • Steinarsdóttir M, Guðmundsson IH, Jónasson JG, Olafsdottir E, Eyfjord JE, Ogmundsdottir HM.  Cytogenetic multiclonality of breast carcinomas: Association with clinico-pathological characteristics and outcome. Genes Chromosomes and Cancer 2011; 50: 930-939.
  • Vidarsdottir H, Jonasson JG, Möller PH.  Krabbamein í botnlanga á Íslandi 1990-2009 – lýðgrunduð rannsókn. Læknablaðið 2011; 97: 537-542.  
    HeimildKrabameinsskrá

Afhending gagna í vísindarannsóknir

Árið 2018

Samþykkt var að veita aðgang að upplýsingum úr Krabbameinsskrá Íslands í eftirfarandi rannsóknir:

Janúar


  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðafræði Rannsókn á erfðafræði hæggengra blóðmeina
    Leyfi VSN 17-145 Ábyrgðarmenn Brynjar Viðarsson, Þorvaldur Jónsson og Kári Stefánsson

  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðafræði eitlakrabbameina
    Leyfi VSN 17-199 Ábyrgðarmenn Bjarni Agnar Agnarsson, Þorvaldur Jónsson og Kári Stefánsson

  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðafræði mergæxla og skyldra blóðsjúkdóma
    Leyfi VSN 17-143. Ábyrgðarmenn Sigurður Yngvi Kristinsson, Þorvaldur Jónsson og Kári Stefánsson

  • Samspil erfða og umhverfisþátta við tilurð og afdrif sjúklinga með krabbamein sem tengjast BRCA breytingum
    Leyfi VSN 06-057-V8. Ábyrgðarmaður Jórunn Erla Eyfjörð

Febrúar


  • Áhættuþættir HPV- tengdra sjúkdóma og kynfæravarta hjá islenskum konum. Spurningakönnun
    Leyfi VSN 17-050-V4. Ábyrgðarmaður Laufey Tryggvadóttir

  • Fylgikvillar við aðgerð krabbameins hjá sjúklingum með ristil- og endaþarmskrabbamein
    Leyfi VSN 16-196-V2. Ábyrgðarmaður Helgi Birgisson
  • Íslenska Krabbameinsverkefnið - Rannsókn á bráðahvítblæði
    Leyfi VSN 17-144. Ábyrgðarmenn Sigrún Reykdal, Þorvaldur Jónsson og Kári Stefánsson
  •  Nýgengi krabbameina meðal flugáhafna
    Leyfi 15-034. Ábyrgðarmaður Vilhjálmur Rafnsson
  •  Samanburður á, ductal cancer in situ, brjóstakrabbameini milli Íslands og Svíþjóðar með tilliti til meðferðar og fleiri þátta gæðaskráningar
    Leyfi VSN 17-003-V2. Ábyrgðarmaður Ásgerður Sverrisdóttir

Mars


  • Legbolskrabbamein á Íslandi
    VSN 15-019-V3. Ábyrgðarmaður Ásgeir Thoroddsen

Apríl


  • Íslenska Krabbameinsverkefnið - Erfðir blöðruhálskirtilskrabbameins
    Leyfi VSN 18-029. Ábyrgðarmenn Rafn Hilmarsson, Þorvaldur Jónsson og Kári Stefánsson

  • Lymfoma og önnur krabbamein í tengslum við ónæmisbælandi meðferð með ónæmisbælandi lyfjum axathioprine og TNF alfa hemlum
    Leyfi VSN  18-040. Ábyrgðarmaður Einar S. Björnsson

Maí

  • Áhættuþættir HPV- tengdra sjúkdóma og kynfæravarta hjá islenskum konum. Spurningakönnun
    Leyfi VSN 17-050-V3. Ábyrgðarmaður Laufey Tryggvadóttir
  • Skimun fyrir einstofna góðkynja mótefnahækkun: Lýðgrunduð slembd klíínísk prófun
    Leyfi VSN 16-022. Ábyrgðarmaður Sigurður Yngvi Kristinsson

Júní

  • Fylgikvillar við aðgerð krabbameins hjá sjúklingum með ristil- og endaþarmskrabbamein
    Leyfi VSN 16-196-V3. Ábyrgðarmaður Helgi Birgisson

  • Húðkrabbamein á Íslandi önnur en sortuæxli: Faraldsfræði , meinafræði og ættfræði í heilu þýði
    Leyfi VSN 18-071. Ábyrgðarmenn Jón Gunnlaugur Jónasson og Jónas Aðalsteinsson
  • Íslenska Krabbameinsverkefnið - Leit að erfðaþáttum sjaldgæfra krabbameina
    Leyfi VSN 17-166. Ábyrgðarmenn Gunnar Bjarni Ragnarsson, Þorvaldur Jónsson og Kári Stefánsson
  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðum lungnakrabbameins
    Leyfi VSN 17-138. Ábyrgðarmenn Steinn Jónsson, Þorvaldur Jónsson og Kári Stefánsson

  • Samanburður á, ductal cancer in situ, brjóstakrabbameini milli Íslands og Svíþjóðar með tilliti til meðferðar og fleiri þátta gæðaskráningar
    Leyfi VSN 17-003-V3. Ábyrgðarmaður Ásgerður Sverrisdóttir

Júlí


  • Afdrif sjúklinga með krabbamein í efri þvagvegum á Íslandi á árunum 2003-2016
    Leyfi VSN 18-005. Ábyrgðarmenn Sigurður Guðjónsson og Oddur Björnsson

September


  • Erfðir heilsufars í kjölfar áfalla-The genetics of morbidity and survival in response to significant life stressors
    Leyfi VSN 16-156. Ábyrgðarmenn Unnur A Valdimarsdóttir og Kári Stefánsson
  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðum góðkynja og illkynja æxla í eggjastokkum
    Leyfi VSN 17-171. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
  • Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í leghálsi og forstigum þess
    Leyfi VSN 17-172. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðum illkynja og góðkynja æxla í legbol
    Leyfi VSN 17-124. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson 
  • Íslenska Krabbameinsverkefnið - Rannsókn á magakrabbameini
    Leyfi VSN 18-097. Ábyrgðarmenn  Þorvaldur Jónson, Agnes Smáradóttir og Kári Stefánsson
  • Íslenska Krabbameinsverkefnið - Rannsókn á erfðum skjaldkirtilskrabbamein
    Leyfi VSN 17-204. Ábyrgðarmenn Hannes Hjartarson, Þorvaldur Jónson og Kári Stefánsson
  • Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í þvaglöðru
    Leyfi VSN. 18-137. Ábyrgðarmenn Sigurður Guðjónsson , Þorvaldur Jónson og Kári Stefánsson
  • Lifrafrumukrabbamein á Íslandsi 1998-2017
    Leyfi VSN 15-167-V1. Ábyrgðarmaður Jón Gunnlaugur Jónasson

Október


  • Íslenska Krabbameinsverkefnið - Rannsókn á ristilsepum og krabbamein í ristli og endaþarmi
    Leyfi VSN 17-137. Ábyrgðarmenn Trausti Valdimarsson, Þorvaldur Jónsson og Kári Stefánsson

  • Krabbamein í smágirni á Íslandi
    Leyfi VSN-18-139. Ábyrgðarmaður Páll Helgi Möller
  • Stökkbreytingar og sviperfðabreytingar í eggjastokka-, eggjaleiðara og lífhimnukrabbameini, á Íslandi 1980-2017
    Leyfi VSN 18-124. Ábyrgðarmaður Stefán Þ. Sigurðsson



Afhending gagna í töflugrunna


Nemendaverkefni

2017

2018


Lög og reglur um vísindarannsóknir

 

Styrkir til vísindarannsókna 

 


Var efnið hjálplegt? Nei